Literature DB >> 14976710

Alternative sources of biologically active substances.

V Bĕhal1.   

Abstract

The majority of antibiotics and substances with diverse biological activity used in medicine are produced by actinomycetes, nonfilamentous bacteria and fungi. Other microorganisms, such as myxobacteria, pseudomonads, nocardias, basidiomycetes, marine microorganisms, enterobacteria, halobacteria, hyperthermophiles etc. are investigated for new biologically active metabolites.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14976710     DOI： 10.1007/bf02993460

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  37 in total

1.  Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics.

Authors:  T Barsby; M T Kelly; S M Gagné; R J Andersen
Journal:  Org Lett       Date:  2001-02-08       Impact factor: 6.005

2.  Isolation and partial characterization of an antibacterial substance produced by Enterococcus faecium.

Authors:  A Pantev; P Kabadjova; M Dalgalarrondo; T Haertlé; I Ivanova; X Dousset; H Prévost; J M Chobert
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

3.  Effects of nitrogen sources on bacteriocin production by Enterococcus faecium A 2000.

Authors:  A Pantev; P Kabadjova; R Valcheva; S Danova; X Dousset; T Haertlé; J M Chobert; I Ivanova
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

4.  Micacocidin A, B and C, novel antimycoplasma agents from Pseudomonas sp. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  S Kobayashi; S Hidaka; Y Kawamura; M Ozaki; Y Hayase
Journal:  J Antibiot (Tokyo)       Date:  1998-03       Impact factor: 2.649

5.  Cytotoxic metabolites produced by a fungal strain from a Sargassum alga.

Authors:  T Amagata; K Minoura; A Numata
Journal:  J Antibiot (Tokyo)       Date:  1998-04       Impact factor: 2.649

6.  Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. I. Production, isolation, physico-chemical properties and structure elucidation.

Authors:  G Lampis; D Deidda; C Maullu; S Petruzzelli; R Pompei; F D Monache; G Satta
Journal:  J Antibiot (Tokyo)       Date:  1996-03       Impact factor: 2.649

7.  Melithiazols, new beta-methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties.

Authors:  F Sasse; B Böhlendorf; M Herrmann; B Kunze; E Forche; H Steinmetz; G Höfle; H Reichenbach; M Hermann
Journal:  J Antibiot (Tokyo)       Date:  1999-08       Impact factor: 2.649

Review 8.  Two-peptide bacteriocins produced by lactic acid bacteria.

Authors:  Sylvie Garneau; Nathaniel I Martin; John C Vederas
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

9.  Nothramicin, a new anthracycline antibiotic from Nocardia sp. MJ896-43F17.

Authors:  I Momose; N Kinoshita; R Sawa; H Naganawa; H Iinuma; M Hamada; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1998-02       Impact factor: 2.649

10.  Collybial, a new antibiotic sesquiterpenoid from Collybia confluens (Basidiomycetes).

Authors:  B Simon; T Anke; U Anders; M Neuhaus; F Hansske
Journal:  Z Naturforsch C J Biosci       Date:  1995 Mar-Apr
View more
  1 in total

1.  Identification of Streptomyces sp. nov. WH26 producing cytotoxic compounds isolated from marine solar saltern in China.

Authors:  Haizhou Liu; Lin Xiao; Jianteng Wei; John C Schmitz; Ming Liu; Cuicui Wang; Linyou Cheng; Ning Wu; Lei Chen; Yuyan Zhang; Xiukun Lin
Journal:  World J Microbiol Biotechnol       Date:  2013-02-19       Impact factor: 3.312
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.